Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1186/s13058-015-0541-z.pdf
Reference36 articles.
1. Cancer IAfRo. Globocan 2012. http://globocan.iarc.fr . Accessed 9 Sept 2014.
2. Fulop T, Larbi A, Witkowski JM, Kotb R, Hirokawa K, Pawelec G. Immunosenescence and cancer. Crit Rev Oncog. 2013;18:489–513.
3. Malas S, Harrasser M, Lacy KE, Karagiannis SN. Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review). Oncol Rep. 2014;32:875–86. doi:10.3892/or.2014.3275.
4. Page DB, Postow MA, Callahan MK, Wolchok JD. Checkpoint modulation in melanoma: an update on ipilimumab and future directions. Curr Oncol Rep. 2013;15:500–8. doi:10.1007/s11912-013-0337-1.
5. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443–54. doi:10.1056/NEJMoa1200690.
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients;Cancers;2024-06-28
2. A Mendelian analysis of the relationships between immune cells and breast cancer;Frontiers in Oncology;2024-01-24
3. Immune cell status, cardiorespiratory fitness and body composition among breast cancer survivors and healthy women: a cross sectional study;Frontiers in Physiology;2023-06-01
4. The effects of exercise training for eight weeks on immune cell characteristics among breast cancer survivors;Frontiers in Sports and Active Living;2023-05-11
5. An Updated Review on Recent Advances in the Usage of Novel Therapeutic Peptides for Breast Cancer Treatment;International Journal of Peptide Research and Therapeutics;2023-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3